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1. Introduction 
The morphine-like peptide ~-er~dorphin @-EP) is 
identical with the C-terminal amino acid sequence 
61-91 of /3-lipotropin (fl-LPH), binds to opiate recep- 
tors and inhibits the PGEr-stimulated increase of 
adenosine 3’5~cyclic monophosphate in neuroblas- 
toma X glioma hybrid cells [l--4]. 
In man @-EP was detnonstrated in cerebrospinal 
fluid [S J as well as in plasma, where it increased 
together with ACTH after methyrapone administra- 
tion [6]. /3-EP was also found in patients with endo- 
crine disorders associated with increased ACTH and 
P-LPH production [7]. Plasma @-EP was 4-5 ng/ml in 
normal [S] and 7-10 r&ml in adrenalectomized rats 
[91- 
The release of growth hormone [ 10,I l] and pro- 
lactin [ 11,121 is stimulated by intraventricular injec- 
tion of &EP in the rat. Intravenous injection of an 
enkeph~in analogue in man raised serum growth 
hormone, prolactin and gtycerol while lactate, alanine 
and glucose were decreased [ 131. 
Here we communicate that porcine /3-EP has lipolytic 
activity in nearly physiologic concentrations in rabbit 
adipocytes which is accompanied by an activation of 
adenylate cyclase in fat cell ghosts. Because these 
effects are not inhibited by naioxone and cannot be 
imitated by opiate agonists, we conclude that this 
effect of /3-endorphin is not mediated by an opiate 
receptor. 
2. Materials and methods 
From lyophilized pig pituitary glands, fraction D’ 
360 
was prepared as in [ 141, fl-LPH as in [ 15,161 and 
0.EP as in [17]. @-LPH and P-EP were characterized 
by amino acid analysis (Liquimat 3, Fa. Kontron, 
Munich), N- and C-terminal amino acid determina- 
tions, SDS-polyacrylamide gel electrophoresis. The 
opiate activity of /3BP in the guinea pig ileum, rat 
and mouse vas deferens systems (tested by Dr R. 
Schulz) and the inhibitory effect on PGEt-stimulated 
CAMP level in neuroblastoma X glioma hybrid cells 
(tested by Dr M. Brandt) were equal to synthetic 
/3-EP. 
Lipolysis in isolated rabbit fat cells was measured 
as described with slight modifications [ 181. Fat cells 
were isolated from perirenaf adipose tissue of 12 h 
starved animals and a11 samples (7-9 X lo4 cells/ml) 
were tested in triplicate for free glycerol content. Fat 
cell ghosts were prepared by the method in [ 191 and 
adenylate cyclase activity was determined according 
to [20]. c[~~P]AMP was purified by column chroma- 
tography with Dowex (AG SO- X4, ‘ZOO--400 mesh, 
H’) and neutral ~uininium oxide (201. 
Naloxone, levorphanol, etorphine, morphine, 
dextrorphan, and Leu-enkephalin were gifts from 
Dr Hamprecht; bovine albumin fraction V was obtained 
from Fa. Roth, Karlsruhe (defatted by the method 
in [Z I]), c 13HJAMP and [o-32P]ATP from Fa. Amersham- 
Buchler, Braunschweig, enzymes and co-substrates from 
Boehringer Mannheim, collagenase type CLs II from 
Fa. Worthington, NJ. a-Endorphin was purchased 
from Fa. Serva, Heidelberg. 
3. Results 
Porcine &EPsignificantly stimulated glycerol release 
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in isolated rabbit fat cells from 8 of 12 animals in 
minimal concentrations of 1 nM. At 10 nM /I-EP was 
lipolytic in all animals. No lipolytic activity could be 
demonstrated for levorphanol, etorphine, morphine, 
dextrorphan, Leu-enkephalin at 10 PM and a-endor- 
phin at 100 nM in two animals. The lipolytic activity 
could not be inhibited by 10 FM naloxone in the 
adipocytes of 8 animals (tig.1). 
In accordance with the lipolytic activity in isolated 
adipocytes P-EP significantly activated adenylate 
cyclase in fat cell ghosts in the range from 10 nM to 
10 PM (fig.2). In 5 different experiments the EDso 
was in the range from 0.07-0.94 PM. The activation 
of adenylate cyclase by /3-EP was not significantly 
inhibited by 10 PM naloxone (fig.2). No activation 
of adenylate cyclase could be demonstrated by the 
opiate agonists listed above at 10 PM. 
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Fig.1. Lipolysis in isolated rabbit fat cells by p-EP (X -X) 
and fl-EP + naloxone (10 PM) (0-o). Basal lypolysis (0). 
Mean values of triplicate determination i SE of a typical 
experiment. 
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Fig.2. Activation of adenylate cyclase in rabbit fat cell ghosts 
by porcine fl-endorphin (0-o). Mean values of triplicate 
determination + SE of a representative experiment is shown 
(n = 5). Values of p-endorphin + naloxone (10 PM) (o-o) 
are compared (n = 2). 
4. Discussion 
The homogenous porcine P-EP preparations tested 
had the same or higher opiate activity in comparison 
to synthetic preparations in organ and cultured cell 
systems. Two new aspects of biological /3-EP activity 
could be demonstrated in concentrations comparable 
to plasma levels in rodents [8,9,22]: the stimulation 
of adenylate cyclase and of lipolysis in adipocytes 
which could not be inhibited by naloxone and could 
not be initiated by opiate agonists. 
The activation of adenylate cyclase in fat cell 
ghosts by /3-EP is in contrast to the data from neural 
tissue where adenylate cyclase is inhibited by opioids 
[23]. Though the actual CAMP concentration remains 
to be determined it is suggested that the intracellular 
activation of lipolysis by fl-EP is mediated by the 
CAMP pathway. This might correspond to the 2-fold 
increase of the intracellular CAMP concentration in 
the mouse prostate gland by morphine [24]. 
The /I-EP preparations tested had a lipolytic activity 
comparable to synthetic &EP [25] but were more 
potent than another porcine fl-EP in rabbit fat pads 
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[26]. Lipolysis of P-EP obviously is not mediated by 
an opiate receptor because there is no inhibition by 
naloxone and no stimulation by several opiate agonists. 
So far an opiate receptor in adipose tissue has not 
been described in literature. Although there is good 
evidence for different types of opiate receptors [27,28], 
the lipolytic activity of /3-EP in isolated adipocytes 
is more likely to be mediated by another kind of 
receptor. Further characterization of this peptide 
receptor is needed. Work is in progress to determine 
the lipolytically active sequence of /I-EP. This is 
obviously located in the C-terminal part of the 
molecule, because neither Leu-enkephalin nor 
cY-endorphin stimulated lipolysis. 
From our data we conclude that the lipolytic and 
adenylate cyclase stimulating effect of fl-EP is not 
mediated by an opiate receptor, which was shown to 
be responsible for other peripheral effects of &EP. 
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